DXCM

DexCom

Halal Rating :
Comfortable
Last Price $80.08 Last updated:
Market Cap $27.79b
7D Change 3.74%
1 Year Change -34.79%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Medical Equipment
  • Surgical
  • Medical
  • And Dental Instruments And Supplies
Exchange NASDAQ
Next Earnings Date Oct. 24, 2024

DexCom, Inc. is a medical device company that focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. The company's primary product line consists of CGM devices that provide real-time glucose readings throughout the day and night, enabling better diabetes management.

The company's flagship products include the DexCom G6 and G7 CGM Systems, which allow diabetes patients to track their glucose levels through a small sensor inserted under the skin, transmitting data to a smartphone or receiver. These systems help users make informed decisions about their diabetes management, including medication, diet, and exercise.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $994.2m $842.2m - - 0.00% 0.00%
June 30, 2024 $1.0b $846.3m - - 0.00% 0.00%
March 31, 2024 $921.0m $819.9m - - 0.00% 0.00%

Company Impact

Help us evaluate DexCom's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates